The global gold standard in targeted prostate biopsy navigation. Artemis integrates pre-biopsy multi-parametric MRI (mpMRI) with real-time transrectal or transperineal ultrasound, empowering urologists with sub-millimeter repeatable tracking and 3D semi-robotic needle guidance.
| Tracking Technology | Mechanical & Optical Joint Encoders (Sub-millimeter spatial accuracy without magnetic interference) |
|---|---|
| Biopsy Approaches Supported | Dual modality: Transperineal (stepper/grid guidance) and Transrectal (freehand robotic tracking) |
| Fusion & Registration Algorithms | Elastic organ modeling compensating for patient movement, probe pressure, and anatomical distortion |
| Ultrasound Compatibility | Vendor-neutral interface (Compatible with BK Medical, GE Healthcare, Mindray, Philips, Hitachi) |
| Imaging & DICOM Standards | DICOM 3.0 import/export, ProFuse MRI segmentation software, full hospital PACS synchronization |
| Approvals & Accreditations | Oman MoH Registered, US FDA 510(k) Cleared, CE Marked Class IIb, ISO 13485:2016 Certified |
Engineered to integrate into operating room suites and outpatient urology clinics with minimum setup overhead.
Radiologists import diagnostic mpMRI files via PACS and outline suspicious PI-RADS lesions and prostate capsules in ProFuse software.
In the OR, the urologist performs a rapid 360-degree rotational ultrasound sweep. Artemis generates a patient-specific 3D prostate model in seconds.
Pre-acquired MRI targets fuse elastically over live ultrasound, adjusting automatically for probe pressure and prostate deformation.
The mechanical tracking arm guides the needle guide directly into the crosshairs, recording the exact 3D coordinates of each core for re-sampling.
Addressing the limitations of conventional random biopsies with verified clinical diagnostic yield.
Direct, verified targeting of index lesions identified on pre-biopsy MRI, providing higher detection rates for clinically significant prostate cancer (csPCa).
Detecting tumors located in anterior, apical, or midline zones that are routinely missed by conventional standard 12-core blind systemic sampling.
The Artemis "electronic biopsy record" remembers exact 3D coordinates, enabling urologists to re-visit the identical biopsy site during surveillance intervals.
Accurate margin delineation and tumor localized coordinate mapping for targeted cryoablation, HIFU, or focal radiation treatment planning.
How semi-robotic mechanical tracking eliminates cognitive human estimation and blind sampling errors.
| Clinical Parameter | Artemis® Semi-Robotic Fusion | Cognitive (Mental) Fusion | Standard 12-Core TRUS |
|---|---|---|---|
| Targeting Accuracy | ✓ Sub-millimeter robotic tracking | Variable (Clinician mental estimate) | Blind systematic sampling |
| Anatomical Motion Compensation | ✓ Elastic deformation modeling | None | None |
| Re-Targeting of Prior Cores | ✓ 3D digital needle coordinates saved | Impossible to replicate | Not reproducible |
| csPCa Detection Yield | ✓ High yield (Significantly fewer misses) | Moderate yield | High false-negative rate |
| Transperineal Stepper Integration | ✓ Full native grid/stepper support | Manual grid alignment | Standard grid template |
Connect directly with our Muscat-based biomedical engineering team for institutional quotations, tender specifications, and in-hospital clinical console demonstrations across Oman and the GCC.
